MAPK8 and Alzheimer disease: Thus, we hypothesize that the administration of CPX-O, which has a special privilege in iron chelation in fungal treatment, either alone or in combination with the JNK inhibitor SP600125, may be of great value in the management of AD through interference with ferroptosis events in the brain.